Accuray to be Acquired by Elekta for $1 Billion
Ticker: ARAY · Form: 8-K · Filed: Dec 11, 2024 · CIK: 1138723
Sentiment: neutral
Topics: acquisition, merger, healthcare
Related Tickers: EKTA
TL;DR
Elekta is buying Accuray for $1B, deal expected to close next year.
AI Summary
Accuray Incorporated announced on December 6, 2024, that it has entered into a definitive agreement to be acquired by Elekta AB for approximately $1.0 billion. The transaction is expected to close in the second half of calendar year 2025, subject to customary closing conditions and regulatory approvals. This acquisition aims to combine two leading companies in the radiation oncology field.
Why It Matters
This acquisition will create a larger, more comprehensive radiation oncology company, potentially impacting market competition and the availability of advanced cancer treatment technologies.
Risk Assessment
Risk Level: medium — The acquisition is subject to regulatory approvals and customary closing conditions, which introduce uncertainty regarding the completion of the transaction.
Key Numbers
- $1.0 billion — Acquisition Value (The total amount Elekta AB will pay to acquire Accuray Incorporated.)
Key Players & Entities
- Accuray Incorporated (company) — Company filing the report and being acquired
- Elekta AB (company) — Acquiring company
- $1.0 billion (dollar_amount) — Purchase price for Accuray Incorporated
- December 6, 2024 (date) — Date of the definitive agreement
- second half of calendar year 2025 (date) — Expected closing period for the acquisition
FAQ
What is the total value of the transaction to acquire Accuray Incorporated?
The definitive agreement states that Elekta AB will acquire Accuray Incorporated for approximately $1.0 billion.
Who is acquiring Accuray Incorporated?
Accuray Incorporated is being acquired by Elekta AB.
When is the acquisition expected to be completed?
The transaction is expected to close in the second half of calendar year 2025.
What are the conditions for the acquisition to close?
The acquisition is subject to customary closing conditions and regulatory approvals.
What is the primary business of Accuray Incorporated and Elekta AB?
Both Accuray Incorporated and Elekta AB are companies in the radiation oncology field.
Filing Stats: 673 words · 3 min read · ~2 pages · Grade level 12.3 · Accepted 2024-12-11 16:01:47
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share ARAY The Nasdaq Stock Mar
Filing Documents
- d838183d8k.htm (8-K) — 24KB
- 0001193125-24-275526.txt ( ) — 140KB
- aray-20241206.xsd (EX-101.SCH) — 3KB
- aray-20241206_lab.xml (EX-101.LAB) — 17KB
- aray-20241206_pre.xml (EX-101.PRE) — 11KB
- d838183d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ACCURAY INCORPORATED Dated: December 11, 2024 By: /s/ Jesse Chew Jesse Chew Senior Vice President, Chief Legal Officer & Corporate Secretary 3